Clinical Trial Update: Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial at the University of Arizona is evaluating the radiotracer 18F-Fluciclovine PET/CT to identify brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: University of Arizona | Conditions: Brain Metastases | Phase 2 | Status: RECRUITING